These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26497206)

  • 1. A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9.
    Goos JA; Coupé VM; van de Wiel MA; Diosdado B; Delis-Van Diemen PM; Hiemstra AC; de Cuba EM; Beliën JA; Menke-van der Houven van Oordt CW; Geldof AA; Meijer GA; Hoekstra OS; Fijneman RJ;
    Oncotarget; 2016 Jan; 7(2):2123-34. PubMed ID: 26497206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases.
    Goos JA; Hiemstra AC; Coupé VM; Diosdado B; Kooijman W; Delis-Van Diemen PM; Karga C; Beliën JA; Menke-van der Houven van Oordt CW; Geldof AA; Meijer GA; Hoekstra OS; Fijneman RJ; ;
    Br J Cancer; 2014 Aug; 111(4):749-55. PubMed ID: 24983372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis.
    Goos JA; de Cuba EM; Coupé VM; Diosdado B; Delis-Van Diemen PM; Karga C; Beliën JA; Menke-Van der Houven van Oordt CW; Geldof AA; Meijer GA; Hoekstra OS; Fijneman RJ;
    Ann Surg; 2016 Jan; 263(1):138-45. PubMed ID: 25563886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis.
    Goos JA; Coupe VM; Diosdado B; Delis-Van Diemen PM; Karga C; Beliën JA; Carvalho B; van den Tol MP; Verheul HM; Geldof AA; Meijer GA; Hoekstra OS; Fijneman RJ;
    Br J Cancer; 2013 Oct; 109(9):2445-52. PubMed ID: 24104968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KISS1 Associates with Better Outcome via Inhibiting Matrix Metalloproteinase-9 in Colorectal Liver Metastasis.
    Zhu C; Takasu C; Morine Y; Bando Y; Ikemoto T; Saito Y; Yamada S; Imura S; Arakawa Y; Shimada M
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1516-23. PubMed ID: 26471489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prokineticin 1 protein expression is a useful new prognostic factor for human sporadic colorectal cancer.
    Nakazawa T; Goi T; Hirono Y; Yamaguchi A
    Ann Surg Oncol; 2015 May; 22(5):1496-503. PubMed ID: 25331005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of prokineticin-receptor2(PK-R2) is a new prognostic factor in human colorectal cancer.
    Goi T; Kurebayashi H; Ueda Y; Naruse T; Nakazawa T; Koneri K; Hirono Y; Katayama K; Yamaguchi A
    Oncotarget; 2015 Oct; 6(31):31758-66. PubMed ID: 26372733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular imaging of aurora kinase A (AURKA) expression: Synthesis and preclinical evaluation of radiolabeled alisertib (MLN8237).
    Goos JACM; Verbeek J; Geldof AA; Hiemstra AC; van de Wiel MA; Adamzek KA; Delis-Van Diemen PM; Stroud SG; Bradley DP; Meijer GA; Hoekstra OS; Fijneman RJA; Windhorst AD
    Nucl Med Biol; 2016 Jan; 43(1):63-72. PubMed ID: 26432753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expression of Notch1, Jagged1, NF-κB and MMP-9 in colorectal cancer patients and the relationship to clinicopathological parameters.
    Zheng CG; Chen R; Xie JB; Liu CB; Jin Z; Jin C
    Cancer Biomark; 2015; 15(6):889-97. PubMed ID: 26406415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic response to preoperative chemotherapy predicts prognosis for patients undergoing surgical resection of colorectal cancer metastatic to the liver.
    Lau LF; Williams DS; Lee ST; Scott AM; Christophi C; Muralidharan V
    Ann Surg Oncol; 2014 Jul; 21(7):2420-8. PubMed ID: 24595797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphatic Invasion is an Independent Adverse Prognostic Factor in Patients with Colorectal Liver Metastasis.
    de Ridder JA; Knijn N; Wiering B; de Wilt JH; Nagtegaal ID
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S638-45. PubMed ID: 25986865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of BMP7 in human colorectal cancer.
    Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
    Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer.
    Ueda M; Iguchi T; Nambara S; Saito T; Komatsu H; Sakimura S; Hirata H; Uchi R; Takano Y; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1490-8. PubMed ID: 26036188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CEA change after neoadjuvant chemotherapy including bevacizumab and clinical outcome in patients undergoing liver resection for colorectal liver metastases.
    Stremitzer S; Stift J; Graf A; Singh J; Starlinger P; Gruenberger B; Tamandl D; Gruenberger T
    Ann Surg Oncol; 2015 Apr; 22(4):1315-23. PubMed ID: 25323471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases.
    Katz SC; Pillarisetty V; Bamboat ZM; Shia J; Hedvat C; Gonen M; Jarnagin W; Fong Y; Blumgart L; D'Angelica M; DeMatteo RP
    Ann Surg Oncol; 2009 Sep; 16(9):2524-30. PubMed ID: 19568816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer.
    de Cuba EM; de Hingh IH; Sluiter NR; Kwakman R; Coupé VM; Beliën JA; Verwaal VJ; Meijerink WJ; Delis-van Diemen PM; Bonjer HJ; Meijer GA; Te Velde EA
    Ann Surg Oncol; 2016 May; 23(5):1601-8. PubMed ID: 26727921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer.
    Yamauchi M; Lochhead P; Imamura Y; Kuchiba A; Liao X; Qian ZR; Nishihara R; Morikawa T; Shima K; Wu K; Giovannucci E; Meyerhardt JA; Fuchs CS; Chan AT; Ogino S
    Cancer Epidemiol Biomarkers Prev; 2013 Jun; 22(6):1142-52. PubMed ID: 23629521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-9 is associated with relapse and prognosis of patients with colorectal cancer.
    Chu D; Zhao Z; Zhou Y; Li Y; Li J; Zheng J; Zhao Q; Wang W
    Ann Surg Oncol; 2012 Jan; 19(1):318-25. PubMed ID: 21455597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.